130 related articles for article (PubMed ID: 9508425)
1. Monoclonal killer toxin-like antiidiotypic antibodies to control rat-pneumocystosis.
Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
J Eukaryot Microbiol; 1997; 44(6):37S. PubMed ID: 9508425
[No Abstract] [Full Text] [Related]
2. Production of anti-toxin antibodies by immunization with Pichia killer toxin-like antiidiotypic monoclonal antibodies.
Snyder C; Seguy N; Lafitte S; Guyard C; Polonelli L; Cailliez JC; Grzych JM
J Eukaryot Microbiol; 1999; 46(5):138S. PubMed ID: 10519290
[No Abstract] [Full Text] [Related]
3. In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies.
Séguy N; Polonelli L; Conti S; Dei-Cas E; Camus D; Cailliez JC
J Eukaryot Microbiol; 1996; 43(5):27S. PubMed ID: 8822831
[No Abstract] [Full Text] [Related]
4. Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.
Séguy N; Cailliez JC; Delcourt P; Conti S; Camus D; Dei-Cas E; Polonelli L
Mol Med; 1997 Aug; 3(8):544-52. PubMed ID: 9307982
[TBL] [Abstract][Full Text] [Related]
5. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
[TBL] [Abstract][Full Text] [Related]
6. The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia.
Cailliez JC; Séguy N; Aliouat EM; Polonelli L; Camus D; Dei-Cas E
Med Hypotheses; 1994 Sep; 43(3):167-71. PubMed ID: 7815973
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
[TBL] [Abstract][Full Text] [Related]
8. Protective antifungal yeast killer toxin-like antibodies.
Magliani W; Conti S; Frazzi R; Ravanetti L; Maffei DL; Polonelli L
Curr Mol Med; 2005 Jun; 5(4):443-52. PubMed ID: 15978000
[TBL] [Abstract][Full Text] [Related]
9. Killer antibodies in fungal infections.
Conti S; Magliani W; Fisicaro P; Dieci E; Arseni S; Salati A; Polonelli L
Res Immunol; 1998; 149(4-5):334-43; discussion 523. PubMed ID: 9720951
[No Abstract] [Full Text] [Related]
10. Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse.
Séguy N; Cailliez JC; Polonelli L; Dei-Cas E; Camus D
Parasitol Res; 1996; 82(2):114-6. PubMed ID: 8825204
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of yeast killer toxin monoclonal antibodies.
Polonelli L; Morace G
J Clin Microbiol; 1987 Feb; 25(2):460-2. PubMed ID: 2434524
[TBL] [Abstract][Full Text] [Related]
12. [Extra-pulmonary pneumocystosis in the course of AIDS. Report of a case].
Terris B; Marche C; Potet F
Ann Pathol; 1996; 16(1):41-4. PubMed ID: 8652000
[TBL] [Abstract][Full Text] [Related]
13. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
[TBL] [Abstract][Full Text] [Related]
14. Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis.
Bradburne RM; Ettensohn DB; Opal SM; McCool FD
Thorax; 1989 Jul; 44(7):591-3. PubMed ID: 2788937
[TBL] [Abstract][Full Text] [Related]
15. In vitro leishmanicidal activity of a monoclonal antibody mimicking a yeast killer toxin.
Savoia D; Avanzini C; Conti S; Magliani V; Frazzi R; Polonelli L
J Eukaryot Microbiol; 2002; 49(4):319-23. PubMed ID: 12188222
[TBL] [Abstract][Full Text] [Related]
16. Killer anti-idiotypes in the control of fungal infections.
Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia.
Ewig S; Schäfer H; Rockstroh JK; Pickenhain A; Lüderitz B
Eur Respir J; 1996 May; 9(5):1006-12. PubMed ID: 8793464
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of pneumocystosis with pentamidine aerosols].
Girard PM; Regnier B
Presse Med; 1991 Jun; 20(24):1139-40. PubMed ID: 1830154
[No Abstract] [Full Text] [Related]
20. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
